Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Tashiro

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neurourology and Urodynamics|September 28, 2020
Overactive bladder medication: Persistence, drug switching, and reinitiationTakeshi Soda, Yu Tashiro, Shuhei Koike, et al.
IJU Case Reports|January 4, 2024
A case of renal cell carcinoma with antiphospholipid syndrome treated by robot-assisted partial nephrectomyYu Tashiro, Satoshi Ishitoya, Ryo Yamamoto, et al.
IJU Case Reports|March 4, 2025
A successful case of urinary rediversion from a complicated cutaneous ureterostomy to a new ileal conduitYu Tashiro, Mami Yamazaki, Yasuaki Katsunaga, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2021
Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapyRihito Aizawa, Kenji Takayama, Kiyonao Nakamura, et al.
International Journal of Clinical Oncology|August 17, 2024
A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamideYu Tashiro, Shusuke Akamatsu, Kentaro Ueno, et al.
Cancer Medicine|May 1, 2021
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohortKatsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, et al.
International Journal of Clinical Oncology|July 19, 2024
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensityHiroshi Fujiwara, Masashi Kubota, Yu Hidaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 21, 2021
Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumabMinoru Kato, Takashi Kobayashi, Yoshiyuki Matsui, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neurourology and Urodynamics|September 28, 2020
Overactive bladder medication: Persistence, drug switching, and reinitiationTakeshi Soda, Yu Tashiro, Shuhei Koike, et al.
IJU Case Reports|January 4, 2024
A case of renal cell carcinoma with antiphospholipid syndrome treated by robot-assisted partial nephrectomyYu Tashiro, Satoshi Ishitoya, Ryo Yamamoto, et al.
IJU Case Reports|March 4, 2025
A successful case of urinary rediversion from a complicated cutaneous ureterostomy to a new ileal conduitYu Tashiro, Mami Yamazaki, Yasuaki Katsunaga, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2021
Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapyRihito Aizawa, Kenji Takayama, Kiyonao Nakamura, et al.
International Journal of Clinical Oncology|August 17, 2024
A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamideYu Tashiro, Shusuke Akamatsu, Kentaro Ueno, et al.
Cancer Medicine|May 1, 2021
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohortKatsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, et al.
International Journal of Clinical Oncology|July 19, 2024
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensityHiroshi Fujiwara, Masashi Kubota, Yu Hidaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 21, 2021
Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumabMinoru Kato, Takashi Kobayashi, Yoshiyuki Matsui, et al.
Pageof 1